3[3]Wainwright D,Madden M,Luterman A,et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J Burn Care Rehabi, 1998; 17(2)∶124
4[4]Grillo HC, McKhann CF. The acceptanae and evolution of dermal homosgrafts freed of viable cells. Transplantation, 1964; 2(1)∶48
5[5]Fang CH, Robb EC, Yu GS,et al. Observation on stability and contraction of composite skin grafts: Xendodermis or allodermis with an isograft onlay. J Burn Care Rehabil, 1990; 1l(9)∶538
6[6]Sasamoto Y, Alexander JW, Babcock GF. Prolonged survival of reconstitoted skin graft without immunosuppression. J Burn Care Rehabil, 1990;1l(3)∶190
7[7]Oliver RF, Grant RA, Kent CM. The fate of cutaneously and subcutsneously implanted trypsin purified dermal collagen in the pig. Br Exp Pathol, 1975;53(9)∶540
3Jacobsen F, Fisahn C, Sorkin M. Efficacy of topically delivered moxifloxacin against wound infection by Pseudornonas aeruginosa and methicillin-resistant Staphylococcus aureus[J]. Antimicrob Agents Chemotherapy, 2011,55 (5) : 2325-2334.
4Jacobsen F, Fisahn C, Sorkin M, Thiele I, Hirsch T, Stricker I, Klaassen T, Roemer A, Fugmann B, Steinstraesser L. Efficacy of topically delivered moxifloxacin against wound infection by Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus[J]. Antimicrob Agents Chemotherapy, 2011, 55(5):2325-2334.
5Hirsch T, Spielmann M, Zuhailil B, Koehler T, Fossum M, Steinau HU, Yao F, Steinstraesser L, Onderdonk AB, Eriksson E. Enhanced susceptibility to infections in a diabetic wound healing model[J]. BMC Surgery, 2008, 8:5.
6Robson MC, Mannari R J, Smith PD, Payne WG. Maintenance of Wound Bacterial Balance[J]. American J Surg, 1999, 178:399- 402.
7Bendy RH, Nuccio PA, Wolfe E. Relationship of quantitative wound bacterial counts to healing of decubiti. Effect of gentamicin[J]. Antimicrob Agent Chemo Ther,1964;4:147-155.
